BRRDF:OTC-Borregaard ASA (USD)

COMMON STOCK | Specialty Chemicals | OTC

Last Closing Price

USD 21.80

Change

0.00 (0.00)%

Market Cap

USD 2.25B

Average Target Price

N/A
Average Analyst Rating

N/A

Fundamental Analysis

Verdict

About

Borregaard ASA develops, produces, and markets specialized biomaterials, biochemicals, and biofuels in Norway, rest of Europe, the United States, Asia, and internationally. It operates through three segments: BioSolutions, BioMaterials, and Fine Chemicals. The BioSolutions segment provides biopolymers for a range of applications, such as agrochemicals, batteries, industrial binders, and construction; and biovanillin for flavor and fragrance companies, as well as for the food and beverage industry. The BioMaterials segment offers specialty cellulose for use as a raw material in the production of cellulose ethers, cellulose acetate, and other specialty products, as well as provides cellulose fibrils for industrial applications. The Fine Chemicals segment provides fine chemical intermediates used for diagnostics; and bioethanol. Borregaard ASA was incorporated in 2012 and is headquartered in Sarpsborg, Norway.

Company Website : http://www.borregaard.com

Address : Hjalmar Wessels vei 6, Sarpsborg, Norway, 1721

Employees : 1,091

Fiscal Year End : December

Currency: USD

Country : USA

Technical Indicators

Beta : 0.05

52 Week High : 21.80

52 Week Low : 10.32

200 Day Moving Average : 16.84

50 Day Moving Average : 21.36

Shares Held By Insiders : 73.39%

Shares Held by Institutions : 68.84%

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-05-13 )

Largest Industry Peers for Specialty Chemicals

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
SKFOF Sika AG

N/A

 USD42.81B 52.04 31.78
SXYAY Sika AG

+0.34 (+1.15%)

 USD42.57B 51.26 31.78
GVDBF Givaudan SA

N/A

 USD39.17B 45.29 32.29
GVDNY Givaudan SA

+1.13 (+1.36%)

 USD38.55B 47.19 32.42
NPCPF Nippon Paint Holdings Co., Ltd

N/A

 USD36.02B 60.94 0.31
RDSMY Koninklijke DSM N.V

+0.51 (+1.14%)

 USD30.61B 50.17 24.15
KDSKF Koninklijke DSM N.V

-0.70 (-0.40%)

 USD30.53B 50.40 24.15
AKZOF Akzo Nobel N.V

N/A

 USD23.07B 27.10 17.85
AKZOY Akzo Nobel N.V

+0.63 (+1.54%)

 USD22.65B 26.00 17.85
EMSHF EMS-CHEMIE HOLDING AG

N/A

 USD21.64B 43.17 37.99

ETFs Containing BRRDF

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Specialty Chemicals)		 Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 53.80% 80% B- 72% C-
Dividend Return 17.64% 93% A 96% A
Total Return 71.44% 81% B- 76% C
Trailing 12 Months  
Capital Gain 164.24% 81% B- 74% C
Dividend Return 58.18% 98% A+ 97% A+
Total Return 222.42% 86% B 79% C+
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 16.87% 65% D 59% F
Dividend Return 14.69% 42% F 95% A
Total Return 31.56% 78% C+ 67% D+
Risk Return Profile  
Volatility (Standard Deviation) 43.07% 46% F 52% F
Risk Adjusted Return 73.27% 88% B+ 92% A-
Market Capitalization 2.25B 52% F 74% C
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Specialty Chemicals)		 Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 37.20 37% F 21% F
Price/Book Ratio 4.61 31% F 28% F
Price / Cash Flow Ratio 2.54 48% F 33% F
EV/EBITDA 2.26 71% C- 59% F
Management Effectiveness  
Return on Equity 12.52% 68% D+ 79% C+
Return on Invested Capital 10.30% 63% D 73% C
Return on Assets 6.37% 83% B 89% B+
Debt to Equity Ratio 37.65% 62% D- 42% F
Technical Ratios  
Short Ratio N/A N/A N/A N/A N/A
Short Percent N/A N/A N/A N/A N/A
Beta 0.05 90% A- 82% B-
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.